JoC: Created page with "{{CaseStudy |Molecular pathological epidemiology (MPE) has contributed to the better understanding of several neoplastic diseases . By connecting putative etiological factors..."

2020-09-11T12:05:59Z

Created page with "{{CaseStudy |Molecular pathological epidemiology (MPE) has contributed to the better understanding of several neoplastic diseases . By connecting putative etiological factors..."

New page

{{CaseStudy

|Molecular pathological epidemiology (MPE) has contributed to the better understanding of several neoplastic diseases . By connecting putative etiological factors to specific molecular signatures across tumour phenotypes, the MPE approach can yield more accurate risk measures regarding PaC. Towards this broad goal, a case-control study will be conducted first on patients with different types of pancreas cancer and pancreatico-biliary diseases to identify associations among potential risk factors and PaC diagnosis and prognosis.

|Patients within Barts Health NHS Trust

|Patients with pancreatic cancers and pancreatico-biliary diseases attending at the hospitals or reported in the GP data since 2010.

|Full GP dataset to include:
*General
*Diagnosis
*Symptoms
*Medical history
*Lifestyle
*Physical exam
*Family history
*Blood test
*Urine test
*Surgical procedures
*Medication-SNOMED

|Anonymised

}}

Molecular Epidemiology Approach Towards Pancreatic Cancer (PaC) - Revision history

JoC: Created page with "{{CaseStudy |Molecular pathological epidemiology (MPE) has contributed to the better understanding of several neoplastic diseases . By connecting putative etiological factors..."